The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer

Respirology

Volumn 16, Issue 2, 2011, Pages 326-331

  Usui, Kazuhiro ^a   Tanai, Chiharu ^a   Tanaka, Yoshiaki ^a   Noda, Hiromichi ^a   Ishihara, Teruo ^a  

^a Kanto Medical Center   (Japan)

Author keywords

combined pulmonary fibrosis and emphysema; interstitial lung disease; lung cancer

Indexed keywords

ACUTE LUNG INJURY; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; EMPHYSEMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG FIBROSIS; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SURVIVAL RATE;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; COMORBIDITY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREVALENCE; PULMONARY EMPHYSEMA; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES; SMOKING; YOUNG ADULT;

EID: 79551552718     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01907.x     Document Type: Article

References (20)

1. Cottin V, Nuns H, Billet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur. Respir. J. 2005; 26: 586-93.
2. Loganathan RS, Stover DE, Shi W, et al. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest 2006; 129: 1305-12.
3. Congleton J, Muers MF,. The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy. Respir. Med. 1995; 89: 291-6.
4. Young RP, Hopkins RJ, Christmas T, et al. COPD prevalence is increased in lung cancer, independently of age, sex and smoking history. Eur. Respir. J. 2009; 34: 380-6.
5. Hubbard R, Venn A, Lewis S, et al. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am. J. Respir. Crit. Care Med. 2000; 101: 5-8.
6. Kawasaki H, Nagai K, Yoshida J, et al. Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis. J. Surg. Oncol. 2002; 81: 33-7.
7. Kitaguchi Y, Fujimoto K, Hanaoka M, et al. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology 2010; 15: 265-71.
8. Katzenstein AL, Mukhopadhyay S, Zanardi C, et al. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum. Pathol. 2010; 41: 316-25.
9. Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008; 452: 633-7.
10. Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008; 452: 638-42.
11. Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet. 2008; 40: 616-22.
12. Lambrechts D, Buysschaert I, Zanen P, et al. The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema. Am. J. Respir. Crit. Care Med. 2010; 181: 486-93.
13. Muroshida T, Wattanapokayakit S, Takahashi A, et al. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J. Med. Genet. 2008; 45: 654-6.
14. Armanios MY, Chen JJ, Cogan JD, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 2007; 356: 1317-26.
15. Cronkhite JT, Xing C, Raghu G, et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2008; 178: 729-37.
16. Savale L, Chaouat A, Bastuji-Garin S, et al. Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2009; 179: 566-71.
17. Jang JS, Choi YY, Lee WK, et al. Telomere length and the risk of lung cancer. Cancer Sci. 2008; 99: 1385-9.
18. Lundblad LK, Thompson-Figueroa J, Leclair T, et al. Tumor necrosis factor-alpha overexpression in lung: a single cause behind a complex phenotype. Am. J. Respir. Crit. Care Med. 2005; 171: 1363-70.
19. Chiyo M, Sekine Y, Iwata T, et al. Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcome. J. Thorac. Cardiovasc. Surg. 2003; 126: 1141-6.
20. Kudoh S, Kato H, Nishiwaki Y, et al. Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study. Am. J. Respir. Crit. Care Med. 2008; 177: 1348-57.